Chardan Capital Initiates PHARMA MAR SA(PHMMF.US) With Buy Rating, Announces Target Price $64.74
Chardan Capital analyst Keay Nakae initiates coverage on $PHARMA MAR SA(PHMMF.US)$ with a buy rating, and sets the target price at $64.97.According to TipRanks data, the analyst has a success rate
Exploring Three Growth Companies Where Insiders Hold The Reins
PHARMA MAR SA To Go Ex-Dividend On June 12th, 2024 With 0.70641 USD Dividend Per Share
April 26th - $PHARMA MAR SA(PHMMF.US)$ is trading ex-dividend on June 12th, 2024. Shareholders of record on June 13th, 2024 will receive 0.71727 USD dividend per share on June 14th, 2024. The ex-d